These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 6427413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D, Tarella C, Gallo E, Ruscetti FW, Breitman TR.
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
    Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K.
    Cancer Res; 1993 May 01; 53(9):2100-4. PubMed ID: 8481912
    [Abstract] [Full Text] [Related]

  • 9. New facts and speculations on human myeloid leukemias.
    Breitman TR, Gallo RC.
    Blood Cells; 1981 May 01; 7(1):79-89. PubMed ID: 6964818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
    Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F, Padula F, Fiorini R, Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG, Nervi C.
    Cancer Res; 2006 Sep 01; 66(17):8903-11. PubMed ID: 16951208
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
    Deubzer H, Busche B, Rönndahl G, Eikel D, Michaelis M, Cinatl J, Schulze S, Nau H, Witt O.
    Leuk Res; 2006 Sep 01; 30(9):1167-75. PubMed ID: 16510182
    [Abstract] [Full Text] [Related]

  • 16. Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
    Kim SH, Kim TS.
    Planta Med; 2002 Oct 01; 68(10):886-90. PubMed ID: 12391550
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.
    Bodner AJ, Ting RC, Gallo RC.
    J Natl Cancer Inst; 1981 Nov 01; 67(5):1025-30. PubMed ID: 6946245
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.
    Haematologica; 2005 Dec 01; 90(12):1607-16. PubMed ID: 16330433
    [Abstract] [Full Text] [Related]

  • 20. [Effects of 9-cis retinoic acid on hematopoiesis in vitro].
    Kizaki M, Nakajima H, Ikeda Y.
    Rinsho Ketsueki; 1994 Mar 01; 35(3):256-60. PubMed ID: 8158845
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.